RT Journal
A1 Michel B, Quelennec B, Andres E
T1 MEdication reconciliation practices and potential clinical impact of unintentional discrepancies
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD February 11
VO 173
IS 3
SP 246
OP 247
DO 10.1001/jamainternmed.2013.1235
UL http://dx.doi.org/10.1001/jamainternmed.2013.1235
AB 
We read with interest the excellent article by Mueller and colleagues1 about hospital-based medication reconciliation practices. We would like to offer some elements about our own experience. The evaluation of the potential clinical impact of the unintentional discrepancies identified and corrected during medication reconciliation process is particularly of high interest. Recently, we have set up conciliation at admission within our hospital and estimated in parallel the potential clinical significance of identified unintentional discrepancies by using a 3-category scale: level 1, “no potential harm”; level 2, “monitoring or intervention potentially required to preclude harm”; and level 3, “potential harm.”